{"id":"NCT02899299","sponsor":"Bristol-Myers Squibb","briefTitle":"Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients","officialTitle":"A Phase III, Randomized, Open Label Trial of Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-11-29","primaryCompletion":"2020-03-25","completion":"2023-04-28","firstPosted":"2016-09-14","resultsPosted":"2021-04-14","lastUpdate":"2024-05-21"},"enrollment":605,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Mesothelioma"],"interventions":[{"type":"BIOLOGICAL","name":"Nivolumab","otherNames":["BMS-936558","Opdivo"]},{"type":"BIOLOGICAL","name":"Ipilimumab","otherNames":["BMS-734016","Yervoy"]},{"type":"DRUG","name":"Pemetrexed","otherNames":[]},{"type":"DRUG","name":"Cisplatin","otherNames":[]},{"type":"DRUG","name":"Carboplatin","otherNames":[]}],"arms":[{"label":"Nivolumab and Ipilimumab","type":"EXPERIMENTAL"},{"label":"Pemetrexed and Cisplatin (or Carboplatin)","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to test the effectiveness and tolerability of the combination of Nivolumab and Ipilimumab compared to Pemetrexed and Cisplatin or Carboplatin in patients with unresectable pleural mesothelioma.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From randomization to the date of death (Up to 40 Months)","effectByArm":[{"arm":"Treatment A","deltaMin":18.07,"sd":null},{"arm":"Treatment B","deltaMin":14.09,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0020"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":109,"countries":["United States","Australia","Belgium","Brazil","Chile","China","Colombia","France","Germany","Greece","Italy","Japan","Mexico","Netherlands","Poland","Romania","Russia","South Africa","Switzerland","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["35367910","35124183","33485464","33206991"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.bmsstudyconnect.com/content/studyconnect/us/en/clinical-trials/NCT02899299.html"]},"adverseEventsSummary":{"seriousAny":{"events":188,"n":300},"commonTop":["Nausea","Fatigue","Anaemia","Decreased appetite","Constipation"]}}